Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 35

Results For "license"

417 News Found

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis
Biotech | December 24, 2021

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis

Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000


Lecanemab granted Fast Track designation by the U.S. FDA
Biotech | December 24, 2021

Lecanemab granted Fast Track designation by the U.S. FDA

Alzheimer's disease is a serious, progressive and devastating disease with few treatment options


World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster
News | December 22, 2021

World Health Organisation SAGE recommends use of Novavax Covid-19 vaccine as booster

SAGE recommends additional third dose of the vaccine administered to immunocompromised persons


Novartis collaborates with BeiGene to strengthen immunotherapy pipeline
Biotech | December 21, 2021

Novartis collaborates with BeiGene to strengthen immunotherapy pipeline

Innovative market development collaboration also signed, expanding the availability of select Novartis oncology products in regions across China currently not covered by Novartis


WHO grants EUL for Covovax
Drug Approval | December 20, 2021

WHO grants EUL for Covovax

First Emergency Use Listing granted by WHO for a protein-based Covid-19 vaccine


ICMR invites EOI for Omicron detection kits
News | December 20, 2021

ICMR invites EOI for Omicron detection kits

The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies


Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials
Biotech | December 10, 2021

Medicago and GSK’s plant based Covid-19 vaccine candidate show promise in Phase 3 trials

Primary endpoints and secondary endpoints for which data are available were met in trial dominated by Covid-19 variants


Dr Reddy’s and Prestige BioPharma collaborate to commercialise trastuzumab biosimilar
Biotech | December 09, 2021

Dr Reddy’s and Prestige BioPharma collaborate to commercialise trastuzumab biosimilar

The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia


Healthium Medtech opens manufacturing facility in Gujarat
News | December 09, 2021

Healthium Medtech opens manufacturing facility in Gujarat

The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.


SPARC partners with Visiox for ophthalmic drugs
Biotech | December 08, 2021

SPARC partners with Visiox for ophthalmic drugs

SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox